21394-91-2

Basic information

• Product Name: Acetamide, N-[4-(1,4,5,6-tetrahydro-6-oxo-3-pyridazinyl)phenyl]-
• CAS NO: 21394-91-2
• Molecular Formula: C12H13N3O2
• Molecular Weight: 231.254
• Mol File: 21394-91-2.mol
• Article Data: 6

Chemical Properties

• CAS DataBase Reference: Acetamide, N-[4-(1,4,5,6-tetrahydro-6-oxo-3-pyridazinyl)phenyl]-(CAS DataBase Reference)
• NIST Chemistry Reference: Acetamide, N-[4-(1,4,5,6-tetrahydro-6-oxo-3-pyridazinyl)phenyl]-(21394-91-2)
• EPA Substance Registry System: Acetamide, N-[4-(1,4,5,6-tetrahydro-6-oxo-3-pyridazinyl)phenyl]-(21394-91-2)

Safety Data

• Hazardous Substances Data: 21394-91-2(Hazardous Substances Data)

Upstream product

• 64-19-7 acetic acid 
• 21282-90-6 6-(4-aminophenyl)-4,5-dihydro-3(2H)-pyridazinone 
• 103-84-4 Acetanilid 
• 5473-15-4 4-(4-acetamidophenyl)-4-oxobutanoic acid 

Downstream Products

• 52241-06-2 6-(4-aminophenyl)-2-methyl-4,5-dihydropyridazine-3(2H)-one 
• 21282-90-6 6-(4-aminophenyl)-4,5-dihydro-3(2H)-pyridazinone 
• 221048-85-7 6-p-acetamidophenyl-4-benzoyl-2(2'-cyanoethyl)pyridazine-3(2H)-one 
• 221048-88-0 N-{4-[5-(4-methoxy-benzoyl)-6-oxo-1,6-dihydro-pyridazin-3-yl]-phenyl}-acetamide 
• 221048-98-2 6-p-acetamidophenyl-4-benzoyl-3-chloropyridazine 
• 221048-87-9 6-p-acetamidophenyl-4-benzoylpyridazin-3(2H)-one 
• 221048-83-5 N-[4-(5-benzyl-1-methyl-6-oxo-1,6-dihydro-pyridazin-3-yl)-phenyl]-acetamide 
• 221048-78-8 N-{4-[5-(4-methoxy-benzyl)-6-oxo-1,6-dihydro-pyridazin-3-yl]-phenyl}-acetamide 
• 95641-07-9 6-p-acetamidophenyl-4-benzylpyridazin-3(2H)-one 

Relevant articles and documents

Repurposing de novo designed entities reveals phosphodiesterase 3B and cathepsin L modulators

Using computational bioactivity prediction models we identified phosphodiesterase 3B (PDE3B) and cathepsin L as macromolecular targets of de novo designed compounds. By disclosing the most potent cathepsin L activator known to date, small molecule repurposing by target panel prediction represents a feasible route towards innovative leads for chemical biology and molecular medicine. This journal is

Novel hydrazone derivatives comprising aryl or heteroaryl group substituted at terminal amine and use thereof

The present invention relates to novel hydrazone derivatives with an aryl or heteroaryl group substituted at a terminal amine group thereof and a use thereof.

6-Aryl-4,5-dihydro-3(2H)-pyridazinones. A new class of compounds with platelet aggregation inhibiting and hypotensive activities

This paper reports on the synthesis and pharmacological activity of 6-aryl-4,5-dihydro-3(2H)-pyridazinone derivatives. The compounds exhibit an aggregation inhibiting action on human platelets in vitro and on rat platelets under ex vivo conditions, as wel